Current Oncology Reports

, Volume 9, Issue 2, pp 96-101

First online:

Cyclooxygenase-2: A novel target in human solid tumors

  • Maria Rosaria RaspolliniAffiliated withDepartment of Human Pathology and Oncology, University of Florence, School of Medicine Email author 
  • , Gian Luigi Taddei

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The enzyme cyclooxygenase-2, which is involved in the conversion of arachidonic acid-to-prostanoid synthesis, plays a key role in many inflammatory and proliferative reactions. Experimental data have shown that prostaglandins have a central action in therapeutic targeting not only in the treatment of many inflammatory diseases but also in several types of human cancers. Inhibitors of cyclooxygenase activity seem to protect against carcinoma development and show promise as chemopreventive agents and possible target therapies. Data support new treatments for patients with solid cancers tailored to the molecular characteristics of the individual tumor.